Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway

被引:112
作者
Seternes, OM [1 ]
Mikalsen, T
Johansen, B
Michaelsen, E
Armstrong, CG
Morrice, NA
Turgeon, B
Meloche, S
Moens, U
Keyse, SM
机构
[1] Univ Tromso, Inst Med Biol, Dept Pharmacol, N-9037 Tromso, Norway
[2] Univ Tromso, Inst Med Biol, Dept Biochem, N-9037 Tromso, Norway
[3] Univ Dundee, Sch Life Sci, MRC, Prot Phosphorylat Unit, Dundee, Scotland
[4] Univ Montreal, Inst Rech Immunovirol & Cancerol, Dept Mol Biol, Montreal, PQ H3C 3J7, Canada
[5] Ninewells Hosp, Mol Pharmacol Unit, Ctr Biomed Res, Canc Res UK, Dundee DD1 9SY, Scotland
关键词
differentiation; ERK3; MK5; phosphorylation; signalling;
D O I
10.1038/sj.emboj.7600489
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular signal-regulated kinase 3 (ERK3) is an atypical mitogen-activated protein kinase ( MAPK), which is regulated by protein stability. However, its function is unknown and no physiological substrates for ERK3 have yet been identified. Here we demonstrate a specific interaction between ERK3 and MAPK-activated protein kinase-5 (MK5). Binding results in nuclear exclusion of both ERK3 and MK5 and is accompanied by ERK3-dependent phosphorylation and activation of MK5 in vitro and in vivo. Endogenous MK5 activity is significantly reduced by siRNA-mediated knockdown of ERK3 and also in fibroblasts derived from ERK3(-/-) mice. Furthermore, increased levels of ERK3 protein detected during nerve growth factor-induced differentiation of PC12 cells are accompanied by an increase in MK5 activity. Conversely, MK5 depletion causes a dramatic reduction in endogenous ERK3 levels. Our data identify the first physiological protein substrate for ERK3 and suggest a functional link between these kinases in which MK5 is a downstream target of ERK3, while MK5 acts as a chaperone for ERK3. Our findings provide valuable tools to further dissect the regulation and biological roles of both ERK3 and MK5.
引用
收藏
页码:4780 / 4791
页数:12
相关论文
共 27 条
[1]   ERKS - A FAMILY OF PROTEIN-SERINE THREONINE KINASES THAT ARE ACTIVATED AND TYROSINE PHOSPHORYLATED IN RESPONSE TO INSULIN AND NGF [J].
BOULTON, TG ;
NYE, SH ;
ROBBINS, DJ ;
IP, NY ;
RADZIEJEWSKA, E ;
MORGENBESSER, SD ;
DEPINHO, RA ;
PANAYOTATOS, N ;
COBB, MH ;
YANCOPOULOS, GD .
CELL, 1991, 65 (04) :663-675
[2]   ERK3 is a constitutively nuclear protein kinase [J].
Cheng, M ;
Boulton, TG ;
Cobb, MH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) :8951-8958
[3]   N-terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome [J].
Coulombe, P ;
Rodier, G ;
Bonneil, E ;
Thibault, P ;
Meloche, S .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (14) :6140-6150
[4]   Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation [J].
Coulombe, P ;
Rodier, G ;
Pelletier, S ;
Pellerin, J ;
Meloche, S .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (13) :4542-4558
[5]  
Crowe DL, 2004, INT J ONCOL, V24, P1159
[6]   SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233
[7]   Signal transduction by the JNK group of MAP kinases [J].
Davis, RJ .
CELL, 2000, 103 (02) :239-252
[8]   Organization and regulation of mitogen-activated protein kinase signaling pathways [J].
Garrington, TP ;
Johnson, GL .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) :211-218
[9]   HETEROGENEOUS EXPRESSION OF 4 MAP KINASE ISOFORMS IN HUMAN TISSUES [J].
GONZALEZ, FA ;
RADEN, DL ;
RIGBY, MR ;
DAVIS, RJ .
FEBS LETTERS, 1992, 304 (2-3) :170-178
[10]   Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases [J].
Johnson, GL ;
Lapadat, R .
SCIENCE, 2002, 298 (5600) :1911-1912